Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 00:32
Narrative updating · score is newerSee how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
BIOCON Sees Accelerating Gross Margin and Marginal Operating Leverage BIOCON's 61.19% has accelerated, up from 6.91%.
The company's .91% has also seen an uptick, up from 2.86%.
Revenue growth has slowed down, with a .6%. Daily volume has declined, moving from 4,586,982 shares to 2,223,200 shares.
The stock's price change percentage stands at .73939097%. Earnings per share (EPS) was not available for the latest quarter.
Analyst sentiment has decreased, with a .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 61.19 % | 6.91 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 6.91 % | 2.86 | ▲ |
| REVENUE_GROWTH_YOY | 10 % | 234.6 | ▼ |
| EPS_ACTUAL | 0.721 INR | 2.738 | ▼ |
| EPS_SURPRISE_PERCENT | -0.254 % | 1.241 | ▼ |
| PRICE_CHANGE_PERCENT | 0.739 % | — | - |
| DAILY_VOLUME | 22,23,200 shares | 45,86,982 | ▼ |
| CLOSE_PRICE | 415.55 INR | 412.5 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.11 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 1 count | 8 | ▼ |
| TARGET_PRICE_PREMIUM | 5.66 % | — | - |